Coherus Biosciences Inc. (CHRS)
NASDAQ · Healthcare
Coherus Biosciences Inc. Cash on Hand 2012–2025
Coherus Biosciences Inc. annual cash on hand history from 2013 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Coherus Biosciences Inc. cash on hand as of December 31, 2025: 88.9M, a 29.45% decrease year-over-year.
- Coherus Biosciences Inc. cash on hand for 2025 were 88.9M, a 29.45% decrease from 2024.
- Coherus Biosciences Inc. cash on hand for 2024 were 126.0M, a 22.45% increase from 2023.
- Coherus Biosciences Inc. cash on hand for 2023 were 102.9M, a 61.91% increase from 2022.
- Coherus Biosciences Inc. cash on hand for 2022 were 63.5M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Coherus Biosciences Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $89 |
| 2024 | $126 |
| 2023 | $103 |
| 2022 | $64 |
| 2021 | $417 |
| 2020 | $541 |
| 2019 | $178 |
| 2018 | $72 |
| 2017 | $127 |
| 2016 | $125 |
| 2015 | $158 |
| 2014 | $150 |
| 2013 | $40 |
Coherus Biosciences Inc. Cash on Hand — FAQ
Coherus Biosciences Inc. (CHRS) cash on hand over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CHRS's cash on hand history?
The chart and table above show Coherus Biosciences Inc.'s cash on hand by year and by quarter, including the growth rate.